Pages that link to "Q43785392"

The following pages link to Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes (Q43785392):

Displaying 28 items.

• A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy (Q33733799) (← links)
• Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats (Q33890767) (← links)
• Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease (Q34475645) (← links)
• Nonhuman primate models of Parkinson's disease (Q34665820) (← links)
• Amine-related neurotoxins in Parkinson's disease: past, present, and future (Q34802001) (← links)
• Update on epidemiological aspects of progressive supranuclear palsy (Q35540189) (← links)
• A guide to neurotoxic animal models of Parkinson's disease (Q35603488) (← links)
• Update on progressive supranuclear palsy (Q35817248) (← links)
• The neuronal mechanism underlying parkinsonism and dyskinesia: differential roles of the putamen and caudate nucleus (Q36446240) (← links)
• Role of mitochondria in the etiology and pathogenesis of Parkinson's disease (Q40437315) (← links)
• Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro (Q41025144) (← links)
• Mitochondrial dysfunction in neurodegeneration (Q41547386) (← links)
• Isoquinoline neurotoxins in the brain and Parkinson's disease (Q41634669) (← links)
• Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease (Q42276779) (← links)
• 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies (Q42452531) (← links)
• 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis. (Q42520791) (← links)
• Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus (Q43037317) (← links)
• 1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation (Q43744070) (← links)
• Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease (Q43768859) (← links)
• Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of gamma-glutamyl transpeptidase in dopaminergic structures of rat brain (Q43818793) (← links)
• Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum (Q44328307) (← links)
• Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups (Q44764021) (← links)
• Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system (Q48576376) (← links)
• Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture (Q48726366) (← links)
• Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats (Q48872683) (← links)
• Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography—tandem mass spectrometry (Q71795338) (← links)
• Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke (Q73292750) (← links)
• Parkinson's disease (Q78747091) (← links)